RPG Life Sciences board member resigns
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
RPG Life Sciences Ltd. said C.T. Renganathan resigned as a director and whole-time director, effective Nov. 30, due to personal reasons.
Mumbai, India-based RPG Life Sciences is an integrated pharmaceutical company that develops branded formulations, generic dosage forms and synthetic active pharmaceutical ingredients.